http://www.curis.com
Curis, Inc. Company Intro
About Curis is a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. We currently have three drug candidates in development: Fimepinostat (formerly known as CUDC-907), an orally available, small molecule inhibitor of HDAC and PI3K enzymes being investigated in a Phase 2 clinical trial in patients with […]
Industry
Healthcare
Curis, Inc. Headquaters
4 Maguire Road
Lexington,02421
United States
Curis, Inc. Share price
14 Sep 2022 08:59 GMT
$0.9700
-0.01 (-0.99 %)
Curis, Inc. Market cap
$86.543 M
WMC RANKING
2022
Curis, Inc. # 168
BiotechnologyLatest Curis, Inc. News
24 Nov 2022
Diffuse Large B-Cell Lymphoma Pipeline | 80+ Companies ...
... BeiGene, Miltenyi Biotec GmbH, Beijing InnoCare Pharma Tech Co., Ltd., Bristol-Myers Squibb, Celleron Therapeutics, Otsuka Pharmaceutical, Curis, Inc.,...
WMC Market Score
WMC Market to Revenue Score
Curis, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Curis, Inc. | USD | $10,315 | $35,013 | $-30,126 | $865M | 168 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Curis, Inc. Social Followers vs Top 4 Industry Competitors
Curis, Inc. Post vs Top 4 Industry Competitors
Curis, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Curis, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Curis, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Curis, Inc. | 0.11 | 1.81 | 0.01 | 0 | 0 | 0 | 0.82 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
